abstract |
The present invention relates to a composition comprising a proline analog compound that is a ligand for a cannabinoid receptor, a proline analog compound and a pharmaceutically acceptable carrier, a method of producing such a proline analog compound, and It relates to a method for treating or preventing a condition comprising administering an effective amount of a proline analog compound to an animal in need thereof. |